These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15203756)

  • 1. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays.
    Wong R; Favaloro E; Pollock W; Wilson R; Hendle M; Adelstein S; Baumgart K; Homes P; Smith S; Steele R; Sturgess A; Gillis D
    Pathology; 2004 Apr; 36(2):182-92. PubMed ID: 15203756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
    Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P
    Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program.
    Wong R; Wilson R; Pollock W; Steele R; Gillis D
    Pathology; 2004 Apr; 36(2):174-81. PubMed ID: 15203755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines on anti-cardiolipin antibody testing and reporting.
    Wong RC; Gillis D; Adelstein S; Baumgart K; Favaloro EJ; Hendle MJ; Homes P; Pollock W; Smith S; Steele RH; Sturgess A; Wilson RJ
    Pathology; 2004 Feb; 36(1):63-8. PubMed ID: 14757559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
    Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.
    Harris EN; Gharavi AE; Patel SP; Hughes GR
    Clin Exp Immunol; 1987 Apr; 68(1):215-22. PubMed ID: 3652514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibodies typical for extrinsic allergic alveolitis--an inter-laboratory quality assessment.
    Aberer W; Woltsche M; Woltsche-Kahr I; Kränke B
    Eur J Med Res; 2001 Nov; 6(11):498-504. PubMed ID: 11726311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hémostase et la Thrombose).
    Reber G; Arvieux J; Comby E; Degenne D; de Moerloose P; Sanmarco M; Potron G
    Thromb Haemost; 1995 Mar; 73(3):444-52. PubMed ID: 7667827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-laboratory comparison of HCV-RNA assay results: implications for multi-centre research.
    Pembrey L; Newell ML; Tovo PA; van Drimmelen H; Quinti I; Furlini G; Galli S; Meliconi MG; Burns S; Hallam N; Sönnerborg A; Cilla G; Serrano E; Laccetti P; Portella G; Polywka S; Icardi G; Bruzzone B; Balbo L; Alfarano A;
    J Med Virol; 2003 Feb; 69(2):195-201. PubMed ID: 12683407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations--a cooperative project of the European Antiphospholipid Forum.
    Tincani A; Allegri F; Sanmarco M; Cinquini M; Taglietti M; Balestrieri G; Koike T; Ichikawa K; Meroni P; Boffa MC
    Thromb Haemost; 2001 Aug; 86(2):575-83. PubMed ID: 11522006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three immunoassays for detection of Toxoplasma-specific immunoglobulin G and M.
    Bacigalupo MA; Bazzini P; Farina L; Ius A
    Eur J Clin Chem Clin Biochem; 1996 Jun; 34(6):503-5. PubMed ID: 8831053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus guidelines for anticardiolipin antibody testing.
    Wong RC;
    Thromb Res; 2004; 114(5-6):559-71. PubMed ID: 15507292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?
    Reber G; Boehlen F; de Moerloose P
    Semin Thromb Hemost; 2008 Jun; 34(4):340-6. PubMed ID: 18814067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing.
    Favaloro EJ; Silvestrini R
    Am J Clin Pathol; 2002 Oct; 118(4):548-57. PubMed ID: 12375642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1.
    Audrain MA; Colonna F; Morio F; Hamidou MA; Muller JY
    Rheumatology (Oxford); 2004 Feb; 43(2):181-5. PubMed ID: 14585922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conclusions of the first French workshop of standardization of anticardiolipin antibody determination associated with autoimmune pathology].
    Abuaf N; Meyer O; Laperche S; Pierron D; Laroche P; Rajoely B; Rouquette AM
    Ann Biol Clin (Paris); 1994; 52(5):365-73. PubMed ID: 7856937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays.
    Reber G; Tincani A; Sanmarco M; de Moerloose P; Boffa MC;
    Thromb Haemost; 2005 Sep; 94(3):665-72. PubMed ID: 16268487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of beta2 -glycoprotein-l antibody testing results from a peer-driven multilaboratory quality assurance program.
    Favaloro EJ; Wong RC; Jovanovich S; Roberts-Thomson P
    Am J Clin Pathol; 2007 Mar; 127(3):441-8. PubMed ID: 17276935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
    Pollock W; Jovanovich S; Savige J
    J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.
    Reber G; Schousboe I; Tincani A; Sanmarco M; Kveder T; de Moerloose P; Boffa MC; Arvieux J
    Thromb Haemost; 2002 Jul; 88(1):66-73. PubMed ID: 12152681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.